23andMe

Precise.ly, the new genomics startup launched by 23andMe co-founder Linda Avey and Aneil Mallavarapu, is taking its spin on direct to consumer personalized genomics to India through a partnership with

All of that genetic material that 23andMe has been collecting is finally being used for commercial drug development — specifically dermatological drugs. The company inked an agreement with Spani

With 12 offices and 350 employees around the world, 3Q Digital is a giant among growth marketing agencies. They’ve worked with companies like Brandless, Opendoor, and Warby Parker, but they also hav

Healthtech is apparently in a golden age. Just a few weeks ago, Livongo and Health Catalyst raised a combined $500 million through IPOs with a joint valuation reaching $3.5 billion...

Why is tech still aiming for the healthcare industry? It seems full of endless regulatory hurdles or stories of misguided founders with no knowledge of the space, running headlong into it, only to fal

In 2009, the National Institutes of Health launched a five-year, $150 million project to stimulate research into a new field of medicine examining the connections between the millions of bacteria livi

Venture capitalists are pouring hundreds of millions of dollars into healthcare startups pitching lower-cost alternatives to traditional services, and one of their primary targets is diagnostics. As i

The seven Africa-focused companies that presented as part of Y Combinator’s Winter 2019 class of 200 startups may seem like a small percentage for such a large class, but it represents the growi

As healthcare moves toward genetically tailored treatments, one of the biggest hurdles to truly personalized medicine is the lack of fast, low-cost genetic testing. And few people are more familiar wi

We explored venture capitalists' latest bets on fertility and contraception tech, including Modern Fertility, Extend Fertility, Natural Cycles, Nurx, Clue and more.

Direct-to-consumer startups — making products that leverage the internet to bypass third-party marketplaces and retailers to engage with and sell directly to their customers — have been on

Are more Theranos -style scandals looming for investors in healthcare startups? A team of researchers associated with the Meta-Research Innovation Center at Stanford thinks so. They’ve publishe

Tiana Kara, the head of partnerships and growth at #builtbygirls, joins us this week to talk about the organization, which connects girls and women between the ages of 15 and 22 with mentors of all st

If you’ve ever enthusiastically sent your spit off in the mail, you were probably anxious for whatever unexpected insights the current crop of DNA testing companies would send back. Did your anc

23andMe, co-founded by CEO Anne Wojcicki, has deployed its latest update, featuring interactive ancestry details, cultural insights about food, art and language, and the option to order a physical an

Longtime NEA general partner Ravi Viswanathan has launched a new fund and brought 31 of NEA's portfolio companies with him.

23andMe, IBM and now uBiome is the next tech company to jump into the lucrative multi-billion dollar drug discovery market. The company started out with a consumer gut health test to check whether you

Vitamins are proving to be a lucrative industry in the United States. Just last year vitamin sales pulled in roughly $37 billion for the U.S. economy. That’s up from $28 billion in 2010. To cas

23andMe is testing a $749 “premium” service for deeper health insights, according to several customers who saw a test page for the new product and posted about it on Reddit. First spotted

23andMe, the genetics testing company, is in a state of constant evolution, as you’d expect any 12-year-old company would be. But that also means that customers need to be aware of how the compa